Drug    DrugBank | All Description Patterns💬 Info on mouse-over

No.	Drug (Description in trials)	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	Disease ID
1	Act-385781a (actelion epoprostenol)	Epoprostenol	[2] D00106, D01337 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
2	Combination injection of epo and g-csf	Filgrastim	[1] D03235 💬	[1] CSF3R 💬	[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	[1]  6  💬
3	Current marketed flolan (epoprostenol sodium)	Epoprostenol	[2] D00106, D01337 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
4	Epo	-	-	-	-	[1] 13 💬
5	Epoeitin beta	-	-	-	-	[1] 18 💬
6	Epoetin alfa	Erythropoietin	[1] D03231 💬	[1] EPOR 💬	[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	[3] 13, 18, 46 💬
7	Epoetin beta	Erythropoietin	[1] D03231 💬	[1] EPOR 💬	[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	[1] 13 💬
8	Epoprostenol	Epoprostenol	[2] D00106, D01337 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
9	Epoprostenol for injection	Epoprostenol	[2] D00106, D01337 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
10	Epoprostenol sodico	Epoprostenol	[2] D00106, D01337 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
11	Epoprostenol sodium	Epoprostenol	[2] D00106, D01337 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
12	Epoprostenol-actelion	Epoprostenol	[2] D00106, D01337 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
13	Epoprostenolo per iniezione	-	-	-	-	[1] 86 💬
14	Erythropoetin (epo)	-	-	-	-	[1]  2  💬
15	Erythropoietin	Erythropoietin	[1] D03231 💬	[1] EPOR 💬	[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	[9]  2 ,  6 , 13, 18, 22, 47, 70, 95, 96 💬
16	Erythropoietin human recombinant (eporh)	Erythropoietin	[1] D03231 💬	[1] EPOR 💬	[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	[1]  6  💬
17	New thermo stable formulation of epoprostenol sodium	Epoprostenol	[2] D00106, D01337 💬	[1] PTGIR 💬	[3] Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction	[1] 86 💬
18	Recombinant human erythropoietin	Erythropoietin	[1] D03231 💬	[1] EPOR 💬	[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	[1] 13 💬
19	Recombinant human erythropoietin(rhepo)	Erythropoietin	[1] D03231 💬	[1] EPOR 💬	[5] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer	[1]  2  💬